COGT
$6.48
Cogent Biosciences
($.19)
(2.85%)
COGT
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.39)
Revenue:  $0.00 Mil
Wednesday
Aug 11
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when COGT reports earnings?
Beat
Meet
Miss

Where is COGT's stock price going from here?
Up
Flat
Down
Stock chart of COGT
Analysts
Summary of analysts' recommendations for COGT
Score
Grade
Pivots
Resistance
$7.08
$6.93
$6.70

$6.55

Support
$6.32
$6.17
$5.94
Tweet
Growth
Description
Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.